ATE170399T1 - Zusammensetzung und verfahren zur behandlung viraler infektionen - Google Patents

Zusammensetzung und verfahren zur behandlung viraler infektionen

Info

Publication number
ATE170399T1
ATE170399T1 AT90905295T AT90905295T ATE170399T1 AT E170399 T1 ATE170399 T1 AT E170399T1 AT 90905295 T AT90905295 T AT 90905295T AT 90905295 T AT90905295 T AT 90905295T AT E170399 T1 ATE170399 T1 AT E170399T1
Authority
AT
Austria
Prior art keywords
composition
viral infections
treating viral
agents
homologs
Prior art date
Application number
AT90905295T
Other languages
English (en)
Inventor
Daniel Meruelo
Gad Lavie
Yehuda Mazur
Original Assignee
Univ New York
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Yeda Res & Dev filed Critical Univ New York
Application granted granted Critical
Publication of ATE170399T1 publication Critical patent/ATE170399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90905295T 1989-03-16 1990-03-16 Zusammensetzung und verfahren zur behandlung viraler infektionen ATE170399T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32417789A 1989-03-16 1989-03-16
US41716389A 1989-10-04 1989-10-04
US48851890A 1990-02-27 1990-02-27

Publications (1)

Publication Number Publication Date
ATE170399T1 true ATE170399T1 (de) 1998-09-15

Family

ID=27406317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90905295T ATE170399T1 (de) 1989-03-16 1990-03-16 Zusammensetzung und verfahren zur behandlung viraler infektionen

Country Status (11)

Country Link
US (1) US6150414A (de)
EP (1) EP0426785B1 (de)
JP (1) JPH04504849A (de)
AT (1) ATE170399T1 (de)
AU (1) AU640131B2 (de)
CA (1) CA2029863C (de)
DE (1) DE69032613T2 (de)
DK (1) DK0426785T3 (de)
ES (1) ES2123499T3 (de)
IL (1) IL93682A (de)
WO (1) WO1990010438A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1746392A (en) * 1991-04-10 1992-11-17 Octamer, Inc. A method for inhibition of retroviral replication
US6576784B1 (en) * 1993-05-27 2003-06-10 Yeda Research And Development Co. Ltd. Antiviral agents
IL121440A0 (en) 1997-07-31 1998-01-04 Yeda Res & Dev The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
ATE347355T1 (de) * 2000-01-31 2006-12-15 Yeda Res & Dev Polycyclische dianthrachinone als antikrebsmittel und antiangiogenesemittel
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2003020876A2 (en) 2001-08-31 2003-03-13 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
JP4076749B2 (ja) * 2001-10-15 2008-04-16 富士フイルム株式会社 導電性有機化合物及び電子素子
US20180280321A1 (en) * 2015-03-12 2018-10-04 The Office Of Innovation Commercialization Compositions and methods that inhibit quorum sensing
DK3423428T3 (da) * 2016-03-01 2024-09-23 Soligenix Inc Systemer og fremgangsmåder til fremstilling af syntetisk hypericin
WO2019109046A1 (en) 2017-11-30 2019-06-06 Arrakis Therapeutics, Inc. Nucleic acid-binding photoprobes and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2707704A (en) * 1951-09-29 1955-05-03 Schenley Ind Inc Process for the preparation of hypericin
US3974186A (en) * 1970-05-14 1976-08-10 Richardson-Merrell Inc. Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4670265A (en) * 1983-07-22 1987-06-02 Sydiskis Robert J Aloe emodin and other anthraquinones and anthraquinone-like compounds from plants virucidal against herpes simplex viruses
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
IL79661A (en) * 1986-08-08 1991-01-31 Yeda Res & Dev Antiviral composition containing hypericin or pseudohypericin
US4898891A (en) * 1987-08-07 1990-02-06 Yeda Research And Development Company Ltd. Antiviral compositions
FI891665A0 (fi) * 1987-08-10 1989-04-07 Univ New York Antivirala blandningar, som innehaoller aromatiska polycykliska dioner och en vaordmetod foer retrovirusinfektioner.
WO1989009055A1 (en) * 1988-03-23 1989-10-05 New York University Antiviral composition containing aromatic polycyclic diones and nucleoside analogs and method for treating retrovirus infections
JPH0244231A (ja) * 1988-08-04 1990-02-14 Fuji Electric Co Ltd 中和滴定装置

Also Published As

Publication number Publication date
DE69032613D1 (de) 1998-10-08
US6150414A (en) 2000-11-21
ES2123499T3 (es) 1999-01-16
DE69032613T2 (de) 1999-02-25
IL93682A (en) 1996-06-18
CA2029863A1 (en) 1990-09-17
EP0426785A4 (en) 1991-11-13
AU5338790A (en) 1990-10-09
DK0426785T3 (da) 1999-05-31
EP0426785B1 (de) 1998-09-02
CA2029863C (en) 2001-10-30
JPH04504849A (ja) 1992-08-27
EP0426785A1 (de) 1991-05-15
WO1990010438A1 (en) 1990-09-20
AU640131B2 (en) 1993-08-19

Similar Documents

Publication Publication Date Title
ATE170399T1 (de) Zusammensetzung und verfahren zur behandlung viraler infektionen
BR9913157A (pt) Processos para tratar ou previnir infecção causada por pelo menos um vìrus das flaviviridae e doenças associadas com a referida infecção e infecção causada por pelo menos um vìrus do gênero hepacivìrus da flaviviridade e doenças associadas com a referida infecção, composição farmacêutica para tratar ou previnir infecções virais, e, composto
DK0473671T3 (da) Anvendelse af sigma-receptorligander til fremstilling af et anxiolytisk middel
EA199901031A1 (ru) Производные бензимидазола
IT1254915B (it) Derivati di adenosina ad attivita' a2 agonista
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ES2165269A1 (es) Derivados de alfa-cetoamidas.
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
BR9711095A (pt) Composto de ciclopentano substituìdo, composição e método para inibir neuraminidase de vìrus influenza e método para tratar infecção de vìrus influenza
MX23889A (es) Derivados de cromanos y tiocromanos, procedimiento para su preparacion y composicion farmaceutica.
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
DK0556332T3 (da) Substituerede tetrahydropyridiner og hydroxypiperidiner som midler til behandling af centralnervesystemet
DK0556329T3 (da) Substituerede piperaziner som midler til behandling af centralnervesystemet
ES2174921T3 (es) Inhibidores de la proteasa del vih.
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz
ATE213231T1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
BR9909870A (pt) Pirrolidinas como inibidores de neuraminidases
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
DE3881864D1 (de) Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
ATE247672T1 (de) Zusammensetzung und diese enthaltende pharmazeutische zubereitung für die behandlung von herpes und verwandten viralen infektionen
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
EA200001028A1 (ru) Производные 2"-деоксигигромицина

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee